| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.8M | +4.7% |
| Cost of Revenue | $31K | -99.2% |
| R&D Expense | $5K | -99.0% |
| SG&A Expense | $7.7M | -15.3% |
| Operating Income | -$7.2M | +10.9% |
| Pre-tax Income | -$5.5M | +39.8% |
| Income Tax | -$150K | -556.3% |
| Net Income | -$23.3M | -156.4% |
| EPS (Basic) | -$214.64 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $217K | +24.2% |
| Inventory | $225K | +2.5% |
| Current Assets | $2.8M | +109.5% |
| Total Assets | $20.2M | -56.5% |
| Current Liabilities | $10.3M | -42.4% |
| Long-term Debt | $892K | -88.0% |
| Total Liabilities | $13.0M | -50.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | -135.8% |
| Capital Expenditures | $43K | -76.4% |
| Investing Cash Flow | -$2.7M | -854.5% |
| Financing Cash Flow | $11.1M | +255.7% |
| Free Cash Flow | -$7.1M | -123.5% |
| -611.0% |
| EPS (Diluted) | -$214.64 | -611.0% |
| Stockholders' Equity |
| $7.2M |
| -43.3% |